Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 653 | 791 | 1,016 | 610 | 424 |
| Operating Income | -653 | -791 | -1,016 | -610 | -424 |
| Interest Expense | 2 | 160 | 7 | 3 | 3 |
| Pre-tax Income | -655 | -951 | -1,023 | -613 | -427 |
| Net Income Continuous | -655 | -951 | -1,023 | -613 | -427 |
| Minority Interests | 75 | -115 | 20 | N/A | N/A |
| Net Income | $-730 | $-836 | $-1,043 | $-613 | $-427 |
| EPS Basic Total Ops | -0.05 | -0.06 | -0.14 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.08 | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.05 | -0.06 | -0.14 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.08 | -0.05 | -0.03 |
| EBITDA(a) | $-640 | $-777 | $-1,016 | $-607 | $-421 |